2022 Annual Meeting | Industry Therapeutic Update from Horizon Therapeutics: UPLIZNA® (inebilizumab-cdon): A Next-Era Treatment Option for NMOSD
Program Materials
Program Evaluations
Event Timeline
07:00 PM - 10:00 PM PDT |
Speaker |
Industry Therapeutic Update from Horizon Therapeutics: UPLIZNA® (inebilizumab-cdon): A Next-Era Treatment Option for NMOSD
|
Faculty Disclosures
Patricia Cole |
No disclosure on file
|